PNPLA3 and Hepatic fibrosis: A nonsynonymous variant in PNPLA3 has been associated with steatosis, steatohepatitis and hepatic fibrosis and its deregulation can lead to increased hepatocellular triglyceride accumulation, impairing lipid remodeling and turnover [45] and development of NAFLD [46].